Experts advise avoiding GLP-1 drugs for eating disorders
Glucagon-like peptide-1 receptor agonists like semaglutide and tirzepatide are transforming obesity and diabetes care by suppressing appetite and slowing gastric emptying. However, their rapid off-label expansion has triggered clinical scrutiny … Read More